HomeACADEMIA
ACADEMIA

6 Drug Makers to Participate in “Drug Redirection Program” for Compounds in Development Limbo: Univ. of Tokyo’s Initiative
(Oct.18.2016)

The University of Tokyo recently announced that six drug makers will participate in its “drug redirection program,” a program through which compounds whose development was suspended by drug makers at the clinical trial stage will be introduced to university researchers for further research that could lead to the discovery of new drugs ...
(LOG IN FOR FULL STORY)

News Calendar